The European Business Development Conference (EBDC) is an annual event for leading decision makers
from biotechnology and pharmaceutical firms. About half of innovative drugs result
from national – and especially international – collaborations.
The EBDC provides a forum for making contacts and discussing topics and trends of relevance to the market.
Reboot for gene and cell therapy: challenges and perspectives
After setbacks in the 90s, gene therapy has returned to the R&D laboratories of pharma and biotech companies.
Transfer of genes is not only key for the production of CAR- or TCR-T-cells to fight cancer. In 2017
the FDA approved the first gene therapy for a genetic disease, a form of retinal dystrophy. Treatments for
diseases of the blood are also far along in the clinical pipeline.
What are challenges and perspectives for cures based on gene therapy?
Exits for Biotechs: Before and After the IPO
Besides the advantages of a public offering around the access to growth capital at the time of an IPO and
thereafter, the preparation of the operation can often be demanding for private organization. Also, the time
after a company went public has its challenges. CEOs and CFOs of European biotech companies who
chose the pan-European exchange Euronext for their IPO discuss their experiences with other experts and
share best practice examples in this session.
Big Data and Digitization: Perspectives for drug development and patient care
The availability of large amounts of biomarker and medical data is revolutionizing medicine and drug
development. How can these vast amounts of data best be used to improve R&D and clinical trials?
How will big data impact the time from drug discovery to market launch and will the use of digital data
revolutionize patient care?
Spotlight talks: Unmet medical needs
Besides the sessions the programme will offer dedicated slots for one-to-one partnerings, company
presentations of innovative biotechs and a networking dinner.
Gain the attention of high class attendees at a conference with a more familiar atmosphere than at common partnering events and apply for a company presentation by registering online to the EBDC (1,095 EUR for members of BIO Deutschland or of one of our international partners, 1,975 EUR for non-members). Or register for regular attendance without presentation (545 EUR for members of BIO Deutschland or of one of our international partners, 985 EUR for non-members):
Weitere Infos finden Sie hier.